- ScreenPro Security (SCRN) announced that its monthly COVID-19 testing operations have increased by 10 per cent since January 2022
- The company began the year with approximately 19,000 tests administered and reached about 21,000 tests in June
- The new Omicron variant, BA.5, has caused the latest spike in infections, fueling demand for continued testing
- Ontario’s Chief Medical Officer of Health reports that PCR tests are now the most accurate test to detect COVID-19 and the newest variants
- ScreenPro has access to the most precise PCR testing to detect new variants
- ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
- ScreenPro Security Inc. (SCRN) opened trading at C$0.035
ScreenPro Security (SCRN) announced that its monthly COVID-19 testing operations have increased by 10 per cent since January 2022.
The company began the year with approximately 19,000 tests administered and reached approximately 21,000 tests in June.
The testing growth and demand is fueled by the seventh wave Canadians are now facing as experts suggest the new Omicron variant, BA.5 has caused the newest spike in infections.
Ontario’s Chief Medical Officer of Health, Dr. Kieran Moore reports that Omicron variants, including BA.5, have impacted the sensitivity of a standard rapid antigen test, reducing sensitivity and accuracy to 50 to 60 per cent. The PCR test is now the most accurate test to detect COVID-19 and the newest variants.
Lena Kozovski, CEO of ScreenPro commented on the news.
“As the latest data shows that rapid antigen testing is not as sensitive for detecting the virus compared to PCR testing, we are pleased to share that we have access to the most precise PCR testing to detect new variants. As Canadians face a seventh wave of Covid with stronger mutations, ScreenPro is equipped to detect accuracy and deliver results to maintain safety.”
ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software.
ScreenPro’s access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to provide COVID testing solutions across Canada.
ScreenPro has its own medical doctor and nursing professionals with on-the-ground support staff and transportation, with access to high-quality PPEs to ensure that clients are protected in all aspects of their testing needs.
ScreenPro Security Inc. (SCRN) opened trading at C$0.035 per share.
